期刊文献+

强心饮对肿瘤坏死因子α诱导的大鼠心肌成纤维细胞增殖和胶原合成以及激活蛋白1 mRNA表达的影响 被引量:5

Activator protein-1 mRNA expression,cell proliferation and collagen synthesis induced by tumor necrosis factor-α in cardiac fibroblasts from rats and the effect of Qiangxin Decoction
下载PDF
导出
摘要 目的:研究激活蛋白1(activator protein-1,AP-1)在肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)诱导新生大鼠心肌成纤维细胞(cardiac fibroblasts,CFs)增殖、胶原合成中的作用,探讨强心饮抑制心肌纤维化的作用机制。方法:胰酶消化法分离培养乳鼠CFs,建立TNFα诱导新生大鼠CFs纤维化模型。将CFs按培养方式不同分为正常对照组、模型组和强心饮5%含药血清组、10%含药血清组和20%含药血清组。治疗24h后,采用荧光实时定量聚和酶链式方法检测不同浓度强心饮对CFs AP-1 mRNA表达的影响,甲基噻唑基四唑法检测强心饮对CFs增殖的影响;羟脯氨酸法检测对CFs胶原合成量的影响。结果:TNF-α作用CFs24h后,与空白对照组相比,AP-1 mRNA表达明显增加(P<0.05),细胞增殖和胶原合成增加(P<0.05);强心饮干预后,CFs增殖和胶原合成减少(P<0.05),AP-1 mRNA表达下调(P<0.05)。结论:强心饮能够抑制TNF-α诱导的CFs增殖和胶原合成增加,具有抗心肌纤维化作用,其机制可能与下调AP-1 mRNA表达有关。 Objective: To investigate the function of activator protein-1 (AP-1) in proliferation and collagen cardiac fibroblasts (CFs) in neonatal rats induced by tumor necrosis factor-α (TNF-α), and to mechanism of Qiangxin Decoction (QXD), a compound traditional Chinese herbal medicine, cardiac fibrosis. Methods: CFs derived from neonatal rats were cultured with enzymatic was induced by TNF-α. The CFs were divided into normal contro synthesis of explore the in reversing dissociation, and fibrosis of the CFs group, untreated group, 5% QXD- containing serum group, 10% QXD-containing serum group and 20% QXD-containing serum group. After 24- hour culture of QXD-containing serum, AP-1 mRNA was detected by real-time fluorescent quantitative polymerase chain reaction; proliferation and collagen synthesis of CFs were assayed by thiazolyl blue assay (MTT) and measured by hydroxyproline respectively, in order to determine the effect of different dosage decoction on the proliferation and collagen synthesis of CFs. Results: After 24-hour stimulation of TNF-α in CFs, compared with those in normal control group, the expression of AP-1 mRNA and cardiac fibroblast proliferation and collagen synthesis increased significantly (P〈0.05). However, Qiangxin Decoction could reduce the expression of AP-1 mRNA and decreased the proliferation and collagen synthesis of CFs significantly (P〈0.05). Conclusion: Qiangxin Decoction can reverse cardiac fibrosis, which may nhibit proliferation and collagen synthesis of CFs induced by TNF-α, and be related to its down-regulation of the expression of AP-1.
作者 沈雁 严世芸
出处 《中西医结合学报》 CAS 2008年第9期946-951,共6页 Journal of Chinese Integrative Medicine
基金 国家自然科学基金资助项目(No30472206) 上海中医药大学附属岳阳中西医结合医院"科技之星"基金项目
关键词 心肌纤维化 心肌重构 肿瘤坏死因子Α 激活蛋白1 强心饮 大鼠 cardiac fibrosis cardiac remodeling tumor necrosis factor-α activator protein-1 Qiangxin Decoction rats
  • 相关文献

参考文献15

  • 1慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2414
  • 2姜秀春,姜秀丽,李树青.心肌纤维化发病机制和防治的研究进展[J].医学综述,2006,12(15):931-933. 被引量:18
  • 3Burlew BS, Weber KT. Connective tissue and the heart. Functional significance and regulatory mechanisms. Cardiol Clin. 2000; 18(3): 435-442.
  • 4周素平,杨成明.炎症和心力衰竭[J].心血管病学进展,2007,28(3):493-496. 被引量:25
  • 5Bond M, Chase AJ, Baker AH. et al. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle ceils. Cardiovasc Res. 2001; 50 (3): 556-565.
  • 6Diwan A, Dibbs Z, Nemoto S, el al. Targeted overexpression of noncleavable and secreted forms of tumor necrosis factor provokes disparate cardiac phenotypes. Circulalion. 2004: 109(2): 262 -268.
  • 7Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res. 1993: 27(3): 341-348.
  • 8Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999; 79(1): 215-262.
  • 9牛杏果,赵玉兰.慢性心力衰竭心肌重塑机制及干预治疗[J].心血管病学进展,2005,26(3):281-284. 被引量:20
  • 10Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med. 2003; 65 (2): 181- 193.

二级参考文献124

  • 1李丹,范哲,李广生.心肌纤维化的调控因素[J].心血管病学进展,2004,25(4):253-257. 被引量:24
  • 2赵连友.治疗原发性高血压的现代概念[J].新医学,2004,35(8):454-458. 被引量:22
  • 3[1]Iwama H, Amagaya S, Ogihara Y, et al. Effect of shosaikoto a Japanese and Chinese traditional herbal medical mixture on the mitogentic activity of lipopolysaccharid: a new pharmacological testing model[J]. JEthonpharmacol, 1987, 21(1) :45
  • 4田代真一."血清药理学"と"血清药化学"-汉方の药理学かう始まつた药物血中浓度测定の新しい世界[J].TDM研究,1998,(5):54.
  • 5Chatterjee S, Stewart AS, Bish LT, et al. Circulation, 2002 ;106(12 Suppl 1): Ⅰ212~Ⅰ217.
  • 6Gidh-Jain M, Huang B, Jain P, et al. J Mol Cell Cardiol,1998 ;30(3) :627~637.
  • 7Prabhu SD, Wang G, Luo J,et al. J Mol Cell Cardiol,2003;35(5) :483~493.
  • 8Sabbah HN,Sharov VG,Gupta RC,et al. J Am Coll Cardiol,2000;36(5) :1 698~1 705.
  • 9Condorelli G, Morisco C, Stassi G, et al. Circulation, 1999 ;99(23) :3 071~3 078.
  • 10Ikeda S, Hamada M, Hiwada K. Clin Sci (Lond), 1999;97(2) :239~246.

共引文献2540

同被引文献78

引证文献5

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部